References
- Bechgaard H. Critical factors influencing gastrointestinal absorption—what is the role of pellets?. Acta Pharmaceutica Technologica 1982; 2: 149–157
- Bianchini R., Bruni G., Gazzaniga A., Vecchio C. d-Indobufen extendedrelease pellets prepared by coating with aqueous polymer dispersions. Drug Development and Industrial Pharmacy 1993; 19: 2021–2042
- Chetty D. J. Pharmaceutical availability studies on newly formulated sustained release pellets of diethylpropion hydrochloride. MPharm Thesis, University of Durban-Westville. 1990
- Dah R. A. A multicentre trial of salbutamol controlled release tablets (Volmax®) and standard salbutamol tablets (Ventolin®) in the management of asthma and chronic brochitis. European Respiratory Journal 1988; 1: 306s
- Eskilson C. Controlled release by microencapsulation. Manufacturing Chemist 1985; 56: 33–39
- Eudragit® Data Sheets. Rohm Pharma, DarmstadtGermany 1989
- Ghebre-Sellasie I., Iyer U., Kubert D. Characterization of a new water-based coating for modified release preparations. Pharmaceutical Technology 1988; 12: 96–106
- Gilligan C. A., Po L. W. A. Factors affecting drug release from a pallet system coated with an aqueous colloidal dispersion. International Journal of Pharmaceutics 1991; 73: 51–68
- Govender T., Dangor C. M., Chetty D. J. Drug release and surface morphology studies on controlled release pellets of salbutamol sulphate. Drug Development and Industrial Pharmacy 1995; 21: 1303–1322
- Govender T., Dangor C. M., Chetty D. J. Microencapsulated Eudragit® RS30D-coated controlled release pellets: the influence of dissolution variables and topographical evaluation. Journal of Microencapsulation 1996; 14: 1–13
- Harris M. R., Ghebre Sellasie I., Nesbitt R. U. A water based coating process for sustained release. Pharmaceutical Technology 1986; 10: 102–107
- Jackson I. M., Roberts S., Timmins P., Sen H. Comparison of laboratory scale processing techniques in the production of coated pellets. Pharmaceutical Technology 1990; 14: 50–56
- Krowczynski L. Oral extended release dosage forms: principles of technology. Extended Release Dosage Forms. CRC Press, Boca Raton, FA 1987; 97–158
- Mathir Z. M. Pharmaceutcal availability on newly formulated oral sustained release pellets containing the antihistamine chlorpheniramine maleate. MPharm Thesis, University of Durban, Westville 1991
- Moore-Gillon J. Volmax® (salbutamol CR 8 mg) in the management of nocturnal asthma: A placebo controlled study. European Respiratory Journal 1988; 2: 306s
- Parikh D. M. Airflow in batch fluid-bed processing. Pharmaceutical Technology 1991; 15: 100–108
- Price A. H., Clissold S. P. Salbutamol in the 1980's. A reappraisal of its clinical efficacy. Drugs 1989; 38: 77–122
- Shargel L., Yu A. B. C. Controlled release drug products. Applied Biopharmacokinetics, 2nd Edition. Appleton Century Crafts, Norwalk, Connecticut 1985; 347–371
- Williams R. L., Upton R. A., Braun R. L., Lin E. T., Liang Gee W., Leeson L. J. Devlopment of a new controlled release formulation of chlorpheniramine maleate using in vitro/in vivo correlations. Journal of Pharmaceutical Sciences 1991; 80: 22–25